Cited by 248Fatty Acid Research and HealthAttention Deficit Hyperactivity DisorderAquaculture Nutrition and Growth

Omega-3 polyunsaturated fatty acids in youths with attention deficit hyperactivity disorder: a systematic review and meta-analysis of clinical trials and biological studies

Open access
Chang, Jane Pei-Chen, Su, Kuan-Pin, Mondelli, Valeria, Pariante, Carmine M·2018·Neuropsychopharmacology

Abstract

The role of omega-3 polyunsaturated fatty acids (omega-3 or n-3 PUFAs) in the pathogenesis and treatment of children and adolescents with attention deficit hyperactivity disorder (ADHD) is unclear. A systematic review followed by meta-analysis was conducted on: (1) randomized controlled trials (RCTs) assessing the effects of n-3 PUFAs on clinical symptoms and cognition in children and adolescent with ADHD; and (2) case–control studies assessing the levels of n-3 PUFAs in blood and buccal tissues of children and adolescents with ADHD. In seven RCTs, totalling n=534 randomized youth with ADHD, n-3 PUFAs supplementation improves ADHD clinical symptom scores (g=0.38, p<0.0001); and in three RCTs, totalling n=214 randomized youth with ADHD, n-3 PUFAs supplementation improves cognitive measures associated with attention (g=1.09, p=0.001). Moreover, children and adolescents with ADHD have lower levels of DHA (seven studies, n=412, g=−0.76, p=0.0002), EPA (seven studies, n=468, g=−0.38, p=0.0008), and total n-3 PUFAs (six studies, n=396, g=−0.58, p=0.0001). In summary, there is evidence that n-3 PUFAs supplementation monotherapy improves clinical symptoms and cognitive performances in children and adolescents with ADHD, and that these youth have a deficiency in n-3 PUFAs levels. Our findings provide further support to the rationale for using n-3 PUFAs as a treatment option for ADHD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/npp.2017.160

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Omega-3 fatty acid supplementation was associated with small-to-medium improvements in ADHD symptoms in three meta-analyses.

    “Omega-3 fatty acid supplementation was associated with small-to-medium improvements in ADHD symptoms in three meta-analyses (ten studies with 699 participants, 16 studies with 1,408 participants, 7 studies with 534 participants) (Bloch and Qawasmi, 2011; Chang et al., 2018; Hawkey and Nigg, 2014).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Chang, J. P.-C., Su, K.-P., Mondelli, V., & Pariante, C. M.
Affiliations
King's College London (GB)
Corresponding author
Chang, Jane Pei-Chen
Venue
Neuropsychopharmacology
Published
2017-07-25
Volume
43
Issue
3
Pages
534-545
ISSN
  • 0893-133X (ISSN-L)
  • 1740-634X
OpenAlex
W2738615641
Cited by
248
References
58
Citations by year
2026: 26 · 2025: 31 · 2024: 29 · 2023: 25 · 2022: 35 · 2021: 28 · 2020: 29 · 2019: 31 · 2018: 10 · 2017: 4
FWCI
2.09
Type
journal article
Language
en
Open access
Locations
  • Neuropsychopharmacology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (publishedVersion, other-oa)
Funders
  • Eli Lilly and Company (MR/J002739/1)
  • South London and Maudsley NHS Foundation Trust (MR/L014815/1, MR/J002739/1)
  • National Institute for Health and Care Research (CL-2008-17-005, MR/J002739/1, MR/L014815/1, NF-SI-0616-10074)
  • Academy of Medical Sciences (AMS-SGCL5-Mondelli)
  • King's College London
  • China Medical University
  • H. Lundbeck A/S
  • Medical Research Council (MR/L014815/1, MR/N029488/1, MR/J002739/1)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Aquaculture Nutrition and Growth
Keywords
omega-3 polyunsaturated fatty acids, attention deficit hyperactivity disorder, children and adolescents, dietary supplementation, docosahexaenoic acid, EPA, ADHD symptoms, cognitive performance, fatty acid deficiency, buccal tissue, blood fatty acid levels
MeSH terms
Adolescent, Attention Deficit Disorder with Hyperactivity, Child, Humans, Fatty Acids, Omega-3, Randomized Controlled Trials as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review